Sigma Healthcare Limited (ASX:SIG)

Market Cap	32.55B -6.6%
Revenue (ttm)	10.83B +80.5%
Net Income	709.18M +33.8%
EPS	0.06 +21.9%
Shares Out	11.50B
PE Ratio	45.90
Forward PE	37.50
Dividend	0.04 (1.41%)
Ex-Dividend Date	Sep 3, 2026

Volume	13,041,368
Open	2.850
Previous Close	2.850
Day's Range	2.790 - 2.870
52-Week Range	2.470 - 3.200
Beta	0.32
Analysts	Buy
Price Target	3.20 (+13.07%)
Est. Earnings	Nov 26, 2026

About Sigma Healthcare

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company oper...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1912
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SIG

Financial Performance

In fiscal year 2026, Sigma Healthcare's revenue was 10.83 billion, an increase of 80.53% compared to the previous year's 6.00 billion. Earnings were 709.18 million, an increase of 33.83%.

Analyst Summary

According to 16 analysts, the average rating for SIG stock is "Buy." The 12-month stock price target is $3.20, which is an increase of 13.07% from the latest price.

Price Target

$3.20

(13.07% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 19, 2026

Data Sources Report a data error